Items tagged with Scientific research
Patients with TB have a dysfunctional circulating B-cell compartment, which normalizes following successful treatment (post)
Abstract
TB Alliance and Takeda announce advancement of joint program investigating promising compounds for novel TB therapies (post)
NEW YORK AND OSAKA (June 21, 2016) — TB Alliance and Takeda Pharmaceutical Company Limited (Headquarters: Osaka, Japan; “Takeda”) announced that they have entered into an agreement that further explores hits generated from a high-throughput screening program conducted to find novel compounds to improve treatment of tuberculosis (TB). The joint research program is funded through the Global Health Innovative Technology (GHIT) Fund, established for the purpose of promoting research and development of pharmaceutical products, vaccines and diagnostics needed for communicable diseases.
Research hones in on new TB drugs (post)
University of Queensland (UQ) scientists are honing in on drug-resistant tuberculosis (TB), in a project which could lead to new antibiotics.
Strengthening immune defence may be solution for treating TB (post)
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports.
Penn State, TB Alliance, and GSK partner to discover new treatments for TB (post)
UNIVERSITY PARK, Pa., June 27, 2016 -- A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Researcher receives grant to understand why some HIV+ individuals avoid 'duet of death' (post)
Case Western Reserve University School of Medicine experts and colleagues in the United States and Africa have received an $11 million, five-year NIH grant to understand why some people living with HIV in Africa avoid becoming infected with the bacterium that causes tuberculosis (TB) despite exposure to high-TB-risk circumstances.
Scientists develop computer models to unravel the complexities of TB infection (post)
Models aim to identify targets for new drugs, biomarkers to predict transition to active infection
Resistance to antibiotics and to immune system are interconnected in bacteria (post)
Antibiotics and the immune system are the two forces that cope with bacterial infections. Now, two studies from Isabel Gordo's laboratory, at Instituto Gulbenkian de Ciência (IGC, Portugal), show for the first time that resistance to antibiotics and to the immune system is interconnected in bacteria. The researchers further discovered that bacteria adaptation to the immune system influences the spectrum of antibiotic resistance and, as a side effect, bacteria become more resistant to some antibiotics, but also more sensitive to other classes of antibiotics. These results were now published in the scientific journals Antimicrobial Agents and Chemotherapy* and Evolutionary Applications**.
Researchers receive $9 million grant to fast track the discovery of new antibiotics (post)
In September 2014, President Obama issued an executive order for “Combating Antibiotic-Resistant Bacteria.” Why the urgency? The Centers for Disease Control and Prevention, the order noted, “estimates that annually at least 2 million illnesses and 23,000 deaths are caused by antibiotic-resistant bacteria in the United States alone.”
No time to wait: Lack of funding for TB drug research threatens projects (post)
Research into desperately needed new tuberculosis (TB) drugs is flagging because governments and pharmaceutical companies are not investing enough in the field, scientists warned on the eve of the 21st International AIDS conference, which begins on Monday (July 18).
Page 17 of 74 · Total posts: 0
←First 16 17 18 Last→